BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35714735)

  • 21. Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date.
    Kalatzis V; Roux AF; Meunier I
    Mol Diagn Ther; 2021 Nov; 25(6):661-675. PubMed ID: 34661884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA.
    Fischer MD; Ochakovski GA; Beier B; Seitz IP; Vaheb Y; Kortuem C; Reichel FFL; Kuehlewein L; Kahle NA; Peters T; Girach A; Zrenner E; Ueffing M; MacLaren RE; Bartz-Schmidt K; Wilhelm B
    Retina; 2020 Jan; 40(1):160-168. PubMed ID: 30308560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Coherence Tomography Angiography (OCT-A) in young choroideremia (CHM) patients.
    Murro V; Mucciolo DP; Giorgio D; Sodi A; Passerini I; Virgili G; Rizzo S
    Ophthalmic Genet; 2019 Jun; 40(3):201-206. PubMed ID: 31135252
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia.
    Hariri AH; Velaga SB; Girach A; Ip MS; Le PV; Lam BL; Fischer MD; Sankila EM; Pennesi ME; Holz FG; MacLaren RE; Birch DG; Hoyng CB; MacDonald IM; Black GC; Tsang SH; Bressler NM; Larsen M; Gorin MB; Webster AR; Sadda SR;
    Am J Ophthalmol; 2017 Jul; 179():110-117. PubMed ID: 28499705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.
    Parmann R; Greenstein VC; Tsang SH; Sparrow JR
    Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):4. PubMed ID: 35816046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.
    Ong T; Pennesi ME; Birch DG; Lam BL; Tsang SH
    Pharm Res; 2019 Jan; 36(2):34. PubMed ID: 30617669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.
    Parker MA; Erker LR; Audo I; Choi D; Mohand-Said S; Sestakauskas K; Benoit P; Appelqvist T; Krahmer M; Ségaut-Prévost C; Lujan BJ; Faridi A; Chegarnov EN; Steinkamp PN; Ku C; da Palma MM; Barale PO; Ayelo-Scheer S; Lauer A; Stout T; Wilson DJ; Weleber RG; Pennesi ME; Sahel JA; Yang P
    Am J Ophthalmol; 2022 Aug; 240():285-301. PubMed ID: 35248547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
    Jacobson SG; Cideciyan AV; Ratnakaram R; Heon E; Schwartz SB; Roman AJ; Peden MC; Aleman TS; Boye SL; Sumaroka A; Conlon TJ; Calcedo R; Pang JJ; Erger KE; Olivares MB; Mullins CL; Swider M; Kaushal S; Feuer WJ; Iannaccone A; Fishman GA; Stone EM; Byrne BJ; Hauswirth WW
    Arch Ophthalmol; 2012 Jan; 130(1):9-24. PubMed ID: 21911650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution images of retinal structure in patients with choroideremia.
    Syed R; Sundquist SM; Ratnam K; Zayit-Soudry S; Zhang Y; Crawford JB; MacDonald IM; Godara P; Rha J; Carroll J; Roorda A; Stepien KE; Duncan JL
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):950-61. PubMed ID: 23299470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in
    O'Neil E; Serrano L; Scoles D; Cunningham KE; Han G; Chiang J; Bennett J; Aleman TS
    Ophthalmic Genet; 2019 Jun; 40(3):267-275. PubMed ID: 31135245
    [No Abstract]   [Full Text] [Related]  

  • 32. Near-infrared autofluorescence in young choroideremia patients.
    Mucciolo DP; Murro V; Giorgio D; Sodi A; Passerini I; Virgili G; Rizzo S
    Ophthalmic Genet; 2019 Oct; 40(5):421-427. PubMed ID: 31544579
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies.
    Abbouda A; Avogaro F; Moosajee M; Vingolo EM
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33445564
    [No Abstract]   [Full Text] [Related]  

  • 35. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
    Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
    Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation.
    Renner AB; Fiebig BS; Cropp E; Weber BH; Kellner U
    Arch Ophthalmol; 2009 Jul; 127(7):907-12. PubMed ID: 19597113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE NATURAL HISTORY OF FULL-FIELD STIMULUS THRESHOLD DECLINE IN CHOROIDEREMIA.
    Dimopoulos IS; Freund PR; Knowles JA; MacDonald IM
    Retina; 2018 Sep; 38(9):1731-1742. PubMed ID: 28800019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Genetic Findings in Korean Patients with Choroideremia.
    Jo WG; Lee CS; Han J
    Korean J Ophthalmol; 2023 Aug; 37(4):285-291. PubMed ID: 37336512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VASCULAR ALTERATIONS REVEALED WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH CHOROIDEREMIA.
    Battaglia Parodi M; Arrigo A; MacLaren RE; Aragona E; Toto L; Mastropasqua R; Manitto MP; Bandello F
    Retina; 2019 Jun; 39(6):1200-1205. PubMed ID: 29543633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular hole surgery in patients with end-stage choroideremia.
    Zinkernagel MS; Groppe M; MacLaren RE
    Ophthalmology; 2013 Aug; 120(8):1592-6. PubMed ID: 23562166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.